Position in ABUS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$909,230
+$104,698 QoQ
Shares Held
189,423
+6.0% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 175 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,721,264 across 329 Biotechnology names. ABUS ranks #142 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in ABUS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $909,230 | 189,423 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $804,532 | 178,785 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $881,432 | 183,250 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $961,499 | 211,784 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $642,117 | 207,805 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $700,641 | 200,757 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $616,715 | 188,598 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $684,814 | 177,874 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $571,857 | 185,067 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $439,786 | 170,460 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $411,560 | 164,624 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $341,510 | 168,232 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $381,379 | 165,817 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $482,154 | 159,127 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $348,416 | 149,535 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $272,824 | 142,840 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $365,644 | 134,924 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $309,258 | 103,778 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $352,181 | 90,535 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $388,090 | 90,464 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $266,391 | 87,918 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||